Tags

Type your tag names separated by a space and hit enter

Optimizing therapeutic effects in patients with comorbidities: drug-resistant tremor, autonomic dysfunction, psychiatric disorders, and cognitive impairment.
Neurol Clin. 2008 Aug; 26(3 Suppl):S29-44, v-vi.NC

Abstract

Parkinsonism is a syndrome characterized by a combination of cardinal features including resting tremor, bradykinesia, rigidity, and loss of postural reflexes. The most common presentation of parkinsonism is the idiopathic variety first described by James Parkinson in 1817 now known as Parkinson's disease (PD). This article focuses on identifying the different subtypes of PD, with the recognition that treatment approaches may differ depending on the initial presenting feature. It also addresses issues related to the recognition and treatment of nonmotor comorbidities of PD, such as autonomic dysfunction and neuropsychiatric problems including depression and dementia.

Authors+Show Affiliations

Clinical Center for Movement Disorders, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9036, USA. schit1@mednet.swmed.edu

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

18774441

Citation

Chitnis, Shilpa. "Optimizing Therapeutic Effects in Patients With Comorbidities: Drug-resistant Tremor, Autonomic Dysfunction, Psychiatric Disorders, and Cognitive Impairment." Neurologic Clinics, vol. 26, no. 3 Suppl, 2008, pp. S29-44, v-vi.
Chitnis S. Optimizing therapeutic effects in patients with comorbidities: drug-resistant tremor, autonomic dysfunction, psychiatric disorders, and cognitive impairment. Neurol Clin. 2008;26(3 Suppl):S29-44, v-vi.
Chitnis, S. (2008). Optimizing therapeutic effects in patients with comorbidities: drug-resistant tremor, autonomic dysfunction, psychiatric disorders, and cognitive impairment. Neurologic Clinics, 26(3 Suppl), S29-44, v-vi. https://doi.org/10.1016/j.ncl.2008.05.005
Chitnis S. Optimizing Therapeutic Effects in Patients With Comorbidities: Drug-resistant Tremor, Autonomic Dysfunction, Psychiatric Disorders, and Cognitive Impairment. Neurol Clin. 2008;26(3 Suppl):S29-44, v-vi. PubMed PMID: 18774441.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Optimizing therapeutic effects in patients with comorbidities: drug-resistant tremor, autonomic dysfunction, psychiatric disorders, and cognitive impairment. A1 - Chitnis,Shilpa, PY - 2008/12/5/pubmed PY - 2009/1/10/medline PY - 2008/12/5/entrez SP - S29-44, v-vi JF - Neurologic clinics JO - Neurol Clin VL - 26 IS - 3 Suppl N2 - Parkinsonism is a syndrome characterized by a combination of cardinal features including resting tremor, bradykinesia, rigidity, and loss of postural reflexes. The most common presentation of parkinsonism is the idiopathic variety first described by James Parkinson in 1817 now known as Parkinson's disease (PD). This article focuses on identifying the different subtypes of PD, with the recognition that treatment approaches may differ depending on the initial presenting feature. It also addresses issues related to the recognition and treatment of nonmotor comorbidities of PD, such as autonomic dysfunction and neuropsychiatric problems including depression and dementia. SN - 0733-8619 UR - https://www.unboundmedicine.com/medline/citation/18774441/Optimizing_therapeutic_effects_in_patients_with_comorbidities:_drug_resistant_tremor_autonomic_dysfunction_psychiatric_disorders_and_cognitive_impairment_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0733-8619(08)00054-6 DB - PRIME DP - Unbound Medicine ER -